TORONTO, Oct. 29, 2018 /CNW/ -
https://www.youtube.com/watch?v=AHqW4xTONvM
The View from the C-Suite video interview series
highlights the unique perspectives of listed companies on Toronto
Stock Exchange and TSX Venture Exchange. Videos provide
insight into how company executives think in the current business
environment. To see the latest View from
the C-Suite videos
visit www.tmxmoney.com/en/news/csuite.html)
About Greenbrook TMS Inc. (TSX: GTMS)
Operating through 43 Company-operated treatment centers,
Greenbrook is a leading provider of TMS, an FDA-cleared,
non-invasive therapy for the treatment of MDD, in the United States. TMS therapy provides local
electromagnetic stimulation to specific brain regions known to be
directly associated with mood regulation. Greenbrook has provided
more than 160,000 TMS treatments to over 4,500 patients struggling
with depression.
About TMX Group (TSX: X)
TMX Group's key subsidiaries operate cash and derivative markets
and clearinghouses for multiple asset classes including equities
and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX
Alpha Exchange, The Canadian Depository for Securities, Montréal
Exchange, Canadian Derivatives Clearing Corporation, Trayport and
other TMX Group companies provide listing markets, trading markets,
clearing facilities, depository services, technology solutions,
data products and other services to the global financial community.
TMX Group is headquartered in Toronto and operates offices across
North America (Montréal,
Calgary, Vancouver and New
York), as well as in key international markets including
London, Beijing and Singapore. For more information about TMX
Group, visit our website at www.tmx.com. Follow TMX Group on
Twitter: @TMXGroup.
SOURCE TMX Group Limited